niacinamide and toxin ii (anemonia sulcata)

niacinamide has been researched along with toxin ii (anemonia sulcata) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akin, I; Albers, S; Borggrefe, M; Cyganek, L; Diecke, S; Dinkel, H; El-Battrawy, I; Huang, M; Kleinsorge, M; Lan, H; Lang, S; Li, X; Liao, Z; Müller, J; Rudic, B; Utikal, J; Wieland, T; Xu, Q; Zhao, Z; Zhong, R; Zhou, X; Zimmermann, WH1

Other Studies

1 other study(ies) available for niacinamide and toxin ii (anemonia sulcata)

ArticleYear
A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2019, Sep-01, Volume: 21, Issue:9

    Topics: Action Potentials; Ajmaline; Brugada Syndrome; Cardiotonic Agents; Case-Control Studies; Cellular Reprogramming Techniques; Cnidarian Venoms; Death, Sudden, Cardiac; Humans; Induced Pluripotent Stem Cells; Loss of Function Mutation; Male; Middle Aged; Morpholines; Mutation; Myocytes, Cardiac; NAV1.8 Voltage-Gated Sodium Channel; Niacinamide; Patch-Clamp Techniques; Phenotype; Tachycardia, Ventricular; Voltage-Gated Sodium Channel Blockers

2019